Rajat Goyal

Rajat Goyal

Assistant Professor

MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana-Ambala

Profile ID RP-003-9002 Joined 2026-03-17 29 articles
0Connections
5
Total Views
29
Total Publications
756
Publication Views

About me

Mr. Rajat Goyal is an Assistant Professor of Pharmaceutical Chemistry at MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana-Ambala, Haryana, India. He completed his Bachelor of Pharmacy (2014-2018) and Master of Pharmacy in Pharmaceutical Chemistry (2018-2020) from the Institute of Pharmaceutical Sciences, Kurukshetra University, Kurukshetra, Haryana, India. In 2021, he qualified the Graduate Pharmacy Aptitude Test (GPAT) and is currently pursuing his Ph.D. at MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana-Ambala, Haryana, India. Mr. Goyal has a strong research profile with an H-index 16 and has authored more than 70 review and research articles, along with 25 book chapters published in reputed international journals. He has also authored one book, currently under proof-reading. His intellectual property portfolio includes three patent applications and one copyright, with one patent and the copyright already published. He actively participated in national and international conferences, faculty development programs, seminars and workshops, and has delivered numerous oral and poster presentations. In recognition of his research excellence, he received the Best Paper Award at the DBT-Sponsored International Conference on “Research Ethics, Clinical Therapeutics and Phytopharmaceutical Drug Research”, organized by MM College of Pharmacy in collaboration with MMIMSR & MMCON, MM(DU), Mullana-Ambala in February 2024. In addition to his academic and research contributions, he serves as a reviewer for several reputed international journals published by Elsevier, Springer, Wiley, Hindawi, and other leading publishers

Articles(29)

Authors: P.C. Sharma, R. Goyal, A. Sharma, D. Sharma, N. Saini, H. Rajak, S. Sharma, V.K. Thakur

DOI: 10.1016/j.mtchem.2020.100296

Volume17
Issue0
Pages100296
Abstract

Cancer is a very risky life-threatening disease having most formidable afflictions in the world. Several anticancer agents are commercially accessible, however, the emergence of acquired drug resistance along with extreme adverse effects of these clinically used anticancer medications are major barriers to the effective chemotherapy. Thus, it is recommended to rationally design the newer drugs with few side effects. Fluoroquinolone derivatives are of pivotal interest for researchers due to their admirable pharmacological and pharmacokinetic profiles. They exhibit several favourable characteristics including, higher bioavailability, excellent tissue penetration and relatively low prevalence of adverse and toxic effects. Due to their potential interventions in carcinogenesis and mutagenesis, the focus of the area of research is nowadays shifting towards anticancer aspects of these compounds. This review shows the recent advancements in the development of novel fluoroquinolones as potential anticancer and cytotoxic agents and structure-activity relationships along with the possible modes of action for further development and recent patents filed/granted related to anticancer activity from the last few years have also been tabulated. Also, this review is an attempt to focus on the various upcoming aspects of fluoroquinolones and provides a newer outlook on the possible roles of fluoroquinolones in the treatment of cancer. Scientific information identified in this paper is expected to be useful for aspiring researchers working on the anticancer activity of fluoroquinolones.

Authors: P.C. Sharma, D. Sharma, A. Sharma, N. Saini, R. Goyal, M. Ola, R. Chawla, V.K. Thakur

DOI: 10.1016/j.mtchem.2020.100349

Volume18
Issue0
Pages100349
Abstract

Despite the adverse effects of microbial hazards on public health, major pharmaceutical firms have left the field of anti-infective development and a dramatic reduction in the number of researcher's intricated in the quest for new specific anti-infective leads. In the non-existence of an efficient forum for antibiotics development and over usage in human beings and animals, bacteria have demoralized this potential by gradually establishing the resistance toward most of the antibiotics used. Thus, the production of novel and successful anti-infective drugs is urgently required to combat this resistance. Hydrazones and hydrazides have mounted as a key-skeleton for the development of active drugs, due to their important biological and pharmacological profiles. Hydrazones are being manufactured as medicines by various investigators to fight against the ailments with maximal effects and minimal toxicity. This paper focuses on the outline of the literature results of recent years, incorporating the work on the anti-infective profile of hydrazone analogues. This review may also act as an excellent basis for the development of new derivatives of hydrazone as potential anti-infective mediators.

Authors: Rajat Goyal, Archana Sharma, Vijay Kumar Thakur, Monika Ola, Prabodh Chander Sharma

DOI: 10.1016/j.crgsc.2020.100044

Volume4
Issue0
Pages100044
Abstract

Fluoroquinolones are of pivotal interest for scientists because of their excellent pharmacological and pharmacokinetic profiles. They have a broad spectrum of antimicrobial activity and show several promising features such as, greater bioavailability, admirable tissue penetration and comparatively lower incidence of antagonistic and lethal effects. These have made the compounds highly desirable to combat several infectious diseases. Various synthetic conventions have been established to hasten the fluoroquinolone’s amination rate and to improve yield. Such methods have significant disadvantages including, costly reagents, usage of vast quantities of harmful solvents, excessive heat and sideways reactions. These drawbacks aren’t appropriate in current pharmaceutical market. Hence, it is highly desirable to develop a newer green and more efficient process for fluoroquinolones synthesis. Green chemistry methodology endeavours to achieve sustainability at the molecular level. The field of green chemistry has shown how chemists can design next-generation products and processes to make them more cost-effective while being virtuous for human health and the environment. This graphical review demonstrates the current developments in the synthesis of fluoroquinolones employing the principles of green chemistry by using the novel, recyclable and environmental-friendly catalysts and solvents.

Authors: Diksha Sharma, Vishal Sharma, Archana Sharma, Rajat Goyal, Rajiv K. Tonk, Vijay Kumar Thakur, Prabodh C. Sharma

DOI: 10.1016/j.scp.2021.100496

Volume23
Issue0
Pages100496
Abstract

The exhaustive exploration of the conventional synthetic approaches for the synthesis of nitrogen and sulphur containing heterocyclic moieties has diverted the attention of researchers towards novel eco-friendly strategies of these compounds. Several green chemistry-based synthetic methods like multi-component single pot reaction, recyclable green-based catalyst, green solvent, reusable solvent, ultrasound-mediated synthesis, the solvent-free and microwave-assisted technique have been developed for the synthesis of thiazole derivatives with anticancer potential. According to the cancer society, almost 14.1 million cancer cases and about 8.2 million deaths due to cancer have been reported, which implies that one of every seven deaths occurs due to cancer disease. The thiazole scaffold is contained in more than 18 FDA-approved drugs, as well as, in several experimental formulations. Among them, alpelisib, a thiazole-based drug with the brand name Pigray®, was approved in 2019 for the treatment of breast cancer. The goal of the present review is to highlight the recent advancements in the green chemistry-based synthesis of thiazole derivatives with the discussion of their structure-activity relationship. Based on innovative eco-friendly reports in synthetic literature, this paper compiled the green strategies-based development of thiazole derivatives from 2012 till now with effective anticancer potential.

Authors: Rajat Goyal, Sumeet Gupta, Prabodh Chander Sharma, Hitesh Chopra

DOI: 10.1134/s1068162025603313

Volume52
Issue1
Pages1
Abstract

A novel series of antioxidant-conjugated mutual prodrugs of naproxen (RJ-01-01–RJ-01-10) was designed and synthesized to mitigate the gastrointestinal (GI) adverse effects associated with the parent drug, naproxen. Methods: The study included molecular docking, synthesis and characterization, in vitro hydrolysis, and biological evaluation. Results and Discussion: The synthesized prodrugs demonstrated high stability in simulated gastric fluid (SGF, pH 1.2), with minimal hydrolysis to the parent naproxen (18.62–24.14%), indicating reduced potential for gastric irritation. Conversely, in simulated intestinal fluid (SIF, pH 7.4), a significantly higher hydrolysis rate (75.07–84.01%) was observed, facilitating drug release and intestinal absorption. In docking studies, compounds RJ-01-04, RJ-01-05, RJ-01-06, RJ-01-08, and RJ-01-09 exhibited the highest binding energies (–13.68, –12.23, –13.74, –12.01, and –13.06 kcal/mol, respectively) compared to naproxen. During in vitro evaluation, RJ-01-04 showed significantly more potent COX-2 inhibition (IC50 = 44.18 ± 1.7 µM) than naproxen (IC50 = 61.48 ± 0.8 µM) and comparable COX-1 inhibition (IC50 = 55.34 ± 0.6 vs. 59.43 ± 0.5 µM for naproxen), indicating dual inhibitory activity. In AGS cells, RJ-01-04 reduced reactive oxygen species (ROS) levels and increased superoxide dismutase (SOD) activity more effectively than naproxen, demonstrating enhanced antioxidant effects. Western blot analysis confirmed downregulation of COX-2 and COX-1 protein expression in AGS cells treated with RJ-01-04. Cytotoxicity assessment (MTT assay) in HEK293 cells revealed that RJ-01-04 exhibited significantly lower cytotoxicity than naproxen. Conclusions: These findings support the mutual prodrug strategy as a promising approach to improve the therapeutic profile of naproxen through antioxidant conjugation.

Authors: Ankit Kumar Dubey, Siva Sai Chandragiri, Abin V. Geevarghese, Bhupinder Kapoor, Monica Gulati, Pooja Rani, Gursharan Singh, Vivek P. Chavda, Rohit Gundamaraju, Himangini Bansal, Rupesh K. Gautam, Rajat Goyal, Michael P. Okoh, Bairong Shen, Rajeev K.

DOI: 10.3389/fphar.2025.1648395

Volume16
Issue0
Pages1638395
Abstract

BackgroundFlavonoids that are widely distributed across various plant species exhibit significant anticancer activity in various preclinical and clinical studies, thus offering promising therapeutic prospects. However, a thorough understanding of their pharmacokinetic properties, drug-likeness characteristics, and safety profile is essential for the translational applicability of these molecules into clinical settings.MethodsA systematic search was carried out using various electronic databases such as PubMed Central, ScienceDirect, Clinical Registry, and Google Scholar, using different keywords like “flavonoids”, “cancer”, “pharmacokinetics”, “toxicity”, “tumor”, and their combinations. Non-English literature was excluded due to language barriers, limited accessibility, non-indexing, and the risk of misinterpreting methods or results, which could compromise the accuracy and reliability of the review.Results and discussionThis review provides an in-depth overview of various mechanistic pathways, such as oxidative stress-mediated and immunomodulatory pathways, that are considered to be responsible for the anti-cancer potential of flavonoids. In addition, the pharmacokinetic properties and toxicity profile of flavonoids have been discussed, which are the crucial factors in their clinical translation. Lastly, the review briefly explores various strategies that can be adopted to improve the effectiveness of flavonoids in the treatment of cancer.ConclusionThis investigation enhances our understanding of the translational potential of flavonoid-based therapies by highlighting these essential elements, bringing us one step closer to the development of effective and safe cancer treatments.

Authors: Maima Matin, Rajeev K. Singla, Artur Jóźwik, Jarosław Olav Horbańczuk, Natalia Ksepka, Kamil Wysocki, Thadiyan Parambil Ijinu, Neenthamadathil Mohandas Krishnakumar, Sreejith Pongillyathundiyil Sasidharan, Ifeoma C. Ezenyi, John Igoli, Fabio Fusi, Sa

DOI: 10.1016/j.crbiot.2025.100329

Volume10
Issue0
Pages100329
Abstract

The Zingiberaceae family, including among others, galangal (Alpinia galanga), turmeric (Curcuma longa), cardamom (Elettaria cardamomum), and ginger (Zingiber officinale), has been widely used in traditional medicine and culinary practices worldwide due to its diverse health-promoting properties. This mini-review aims to provide a concise overview of Zingiberaceae species’ medicinal potential and identify key areas for further research to facilitate their integration into modern medicine. Herein we summarize the existing research on the pharmacological activities of these species, with a focus on their antioxidant, anti-inflammatory, antimicrobial, anticancer, cardiovascular, digestive, and metabolic effects. Aside from the reported biological effects of traditional formulations and phytopharmaceutical preparations, emphasis is given to the primary bioactive compounds identified in these plants including diverse phenolics, terpenes, and various other secondary metabolites. Mechanisms contributing to therapeutic benefits. Moreover, highlighted is the promise of these plants for future development of drugs and nutraceuticals despite current challenges, particularly bioavailability issues and the need for more clinical studies.

Authors: Sumel Ashique, Anas Islam, Prashant Kumar, Samy Selim, Soad K. Al Jaouni, Ananya Chakraborty, Ivan Kahwa, Rajat Goyal, Shivani Chopra, Hitesh Chopra

DOI: 10.2174/0113816128383966250726122514

Volume32
Issue12
Pages901-917
Abstract

Apitherapy, the therapeutic use of bee products, has attracted attention for its potential in treating various ailments. Honey is unique among bee products because it has a high concentration of medicinal chemicals. In recent years, there has been growing concern about exploring the neuroprotective features of honey. Our article aimed to consolidate existing research on the neuroprotective potential of honey, shedding more focus on its mechanisms of action and therapeutic properties. The literature suggests that honey exhibits neuroprotective properties by attenuating oxidative stress, alleviating neuroinflammation, and enhancing neuronal survival and regeneration. Especially, honey’s potential to mitigate neurodegenerative disorders and enhance cognitive function and memory. These reports position honey as a promising candidate for neuroprotection, offering a natural and accessible therapeutic option to combat neurological disorders. Its multifaceted mechanism of action makes it a valuable asset in neurotherapy. However, more research is warranted to clarify the specific compounds responsible for their neuroprotective effects and to optimize their therapeutic application. Unlocking the full potential of honey in neuroprotection could open the door to novel therapeutic approaches for the management of neurological conditions.

Authors: Karan Goel, Dhirendra Singh, Rajat Goyal, Seema Bansal, Sukhbir Singh, Neelam Sharma, Sumeet Gupta

DOI: 10.1007/s10787-025-01850-7

Volume33
Issue8
Pages4205-4235
Abstract

Leukotrienes are strong lipid mediators that mainly act through particular leukotriene receptors to produce a broad range of clinical effects. These receptors facilitate the complex biochemical and physiological responses associated with leukotrienes. An examination of their roles in various diseases reveals the pharmacological effects of anti-leukotriene agents, specifically their ability to modulate inflammatory responses within the body. Recent research has focused on the dual nature of these lipids, revealing that they may trigger a mild inflammatory response, which is a key significant factor in neurological diseases, cardiovascular diseases, metabolic syndromes, renal difficulties, liver damage, and cancer. Among the available modulators, Montelukast is distinguished as a particularly effective orally active leukotriene receptor antagonist. In the United States and around the world, it has been available and generally approved for the treatment of hay fever and asthma for more than 11 years. It is frequently recommended as an adjuvant to low-dose inhaled corticosteroids for patients who need additional medication, or as an alternative first-line treatment for pediatric asthma, even in cases with mild, persistent symptoms. Apart from anti-asthmatic and anti-allergic activities, Montelukast has numerous pharmacological activities such as anticancer, neuroprotective, anti-osteoporotic, renal protective, liver protective, cardioprotective, anti-arthritic effects, and other beneficial effects on the body. Montelukast operates through a highly effective mechanism that makes it a potent ally in the battle against various respiratory conditions, including asthma and hay fever.

Authors: Pooja Mittal, Rupesh Kumar Gautam, Himanshu Sharma, Rajat Goyal, Garima, Ramit Kapoor, Dileep Kumar, Mohammad Amjad Kamal, Shafiul Haque, Siva Nageswara Rao Gajula

DOI: 10.2174/011570159x353727250314065140

Volume23
Issue14
Pages1878-1893
Abstract

The review focuses on the ways that ontologies are revolutionising precision medicine in their effort to understand neurodegenerative illnesses. Ontologies, which are structured frameworks that outline the relationships between concepts in a certain field, offer a crucial foundation for combining different biological data. Novel insights into the construction of a precision medicine approach to treat neurodegenerative diseases (NDDs) are given by growing advancements in the area of pharmacogenomics. Affected parts of the central nervous system may develop neurological disorders, including Alzheimer's, Parkinson's, autism spectrum, and attention-deficit/hyperactivity disorder. These models allow for standard and helpful data marking, which is needed for crossdisciplinary study and teamwork. With case studies, you can see how ontologies have been used to find biomarkers, understand how sicknesses work, and make models for predicting how drugs will work and how the disease will get worse. For example, problems with data quality, meaning variety, and the need for constant changes to reflect the growing body of scientific knowledge are discussed in this review. It also looks at how semantic data can be mixed with cutting-edge computer methods such as artificial intelligence and machine learning to make brain disease diagnostic and prediction models more exact and accurate. These collaborative networks aim to identify patients at risk, identify patients in the preclinical or early stages of illness, and develop tailored preventative interventions to enhance patient quality of life and prognosis. They also seek to identify new, robust, and effective methods for these patient identification tasks. To this end, the current study has been considered to examine the essential components that may be part of precise and tailored therapy plans used for neurodegenerative illnesses.

Authors: Rajat Goyal, Kumar Susheel, Kajal Garg, Rani Neha, Hitesh Chopra, Kashish Wilson, Sumeet Gupta

DOI: 10.5937/scriptamed56-52345

Volume56
Issue2
Pages315-328
Abstract

Tuberculosis (TB), a bacterial disease primarily affecting middleas well as low-income countries, poses a significant public health threat. Natural products have historically been and remain a vital source of fresh medications for treating various diseases. The renewed interest in natural product research is partly a result of the increasing prevalence of drug-resistant Mycobacterium tuberculosis (MTb) strains along with adverse outcomes associated with firstand second-line anti-tubercular drugs. The TB complexity and the complications arising from the use of allopathic medications, such as multidrug resistance, highlight the effectiveness of natural medications in this context. Therefore, it is crucial to explore new treatment therapies to effectively mitigate the harmful effects associated with TB. More research is needed on various natural substances, both independently and in combination with currently approved drug regimens, as potential TB treatment options.

Authors: Shaheen Husain, Rania Mohammad Sabri Sultan, Kirti Saxena, Fareha Bano, Rajat Goyal, Shivani Chopra, Hitesh Chopra, Suresh K. Verma

DOI: 10.2174/0113816128346637250401090138

Volume31
Issue35
Pages2795-2819
Abstract

Background: Due to increasing antibiotic resistance, researchers are investigating the medicinal potential of nanoparticles, particularly their antibacterial and antiviral properties. Among other things, this concern mandates the journey for novel and more potent antibacterial drugs. The crucial role of nanoparticles in the treatment of various microbial diseases has been demonstrated in several research studies. Aim & Objective: This study focuses on the role of Selenium nanoparticles (SeNPs) against infectious diseases, with an emphasis on exploring their probable mechanisms of action. Methodology: Nanoparticles have been exploited as delivery mechanisms and broad-spectrum inhibitors in viral and microbial studies. Their significant therapeutic potential stems from their high surface area to volume ratio, which enables diverse applications. Various materials have been employed in the synthesis of nanoparticles, each tailored to meet specific therapeutic requirements. The unique combination of biological relevance, environmental friendliness, and versatile applications makes SeNPs a promising alternative to other nanoparticles in various fields. Results: The therapeutic potential of nanoparticles, especially Selenium nanoparticles (SeNPs), is significant and warrants further exploration. They have shown promise as delivery agents and potent materials for combating infectious diseases, making them a valuable asset in the fight against antibiotic resistance. Conclusion: Selenium nanoparticles (SeNPs) are potential biological prospects because of their biocompatibility, bioavailability, and low toxicity. Size, shape, and synthesis affect SeNP uses in biological systems. SeNPs are chemopreventive, anti-inflammatory, and antioxidant medicines that may cure fungal, bacterial, and parasite infections, cancer, and diabetes. They have better absorption, bioavailability, and antibacterial action than micron-size particles. Their large surface area facilitates biological contact and bioactive chemical functionalization. Functionalized SeNPs are less cytotoxic than other seleniums. They prevent DNA oxidation, detoxify heavy metals, and inhibit hydroxyl radicals. In conclusion, selenium nanoparticles have considerable promise for medication delivery, antimicrobials, and cancer and diabetes treatment. They are attractive nanomedicine prospects due to their low toxicity, biocompatibility, and high bioavailability.

Authors: Kashish Wilson, G Garima, Rajat Goyal, Hitesh Chopra, Shivani Chopra, Meenakshi Dhanawat

DOI: 10.5937/scriptamed56-52565

Volume56
Issue1
Pages185-197
Abstract

Monkeypox virus (MPXV) is a close relative of the Variola (smallpox) virus, which was formerly prevalent throughout West and Central Africa. Nonetheless, instances have lately been verified outside of Africa in several nonendemic nations. Considering the COVID-19 pandemic, the World Health Organization (WHO) defined the recent monkeypox spread health emergency for the public for global significance on 23 July 2022. This worldwide community may be in danger because of the increased number of confirmed cases. The monkeypox virus (MPXV), the etiologic agent, was isolated from diseased monkeys in 1959, and its pathogenicity in humans was first documented in the 1970s, primarily in Western and Central African endemic countries. But in 2022, this disease shows extreme return at a never-before-seen rate, raising concerns about its communicative expansion in non-endemic areas and its potential for human-to-human transmission. Healthcare professionals, public health regulators and the general people around the world must possess substantial expertise for such relatively unknown viral diseases to mitigate the situation. Here, a thorough and current pathogenesis overview, epidemiology and clinical characteristics, along with monkeypox therapy is presented. This current review also covers future research fields, vaccine advancements and preventive and control methods for this reemerging viral disease that is currently recognised as a global crisis in public health.

Authors: Tanvi -, Rajat Goyal, Rupesh K. Gautam, Kashish Wilson, Kajal Garg, Tanmay Sharma, Sumeet Gupta, Sachin Kumar Singh, Haider Ali, Gaurav Gupta, Md Sadique Hussain

DOI: 10.2174/0126667975359293250210050445

Volume7
Issue3
Pages1-15
Abstract

Abstract: Animal coronaviruses (CoVs) have emerged as significant pathogens with considerable implications for both animal and human health. This review provides an in-depth analysis of the origins, transmission dynamics, and pathogenic mechanisms of animal CoVs. We examine the viral entry, replication processes, and immune evasion strategies that enable CoVs to infect a variety of host species. Additionally, the review highlights recent advancements in prevention and therapeutic strategies, including the development of species-specific vaccines, enhanced biosecurity measures, and surveillance systems aimed at controlling zoonotic spillover. Furthermore, we discuss the latest antiviral strategies, including repurposed drugs, targeted molecular therapies, and the development of novel antiviral agents. This review emphasizes the importance of interdisciplinary research in advancing our understanding of animal CoVs and in developing effective interventions to mitigate their impact on global health.

Authors: Kalpesh Mahajan, Sanjay Sharma, Rupesh K Gautam, Rajat Goyal, Dinesh Kumar Mishra, Rajeev K Singla

DOI: 10.1177/13872877241296557

Volume102
Issue4
Pages897-923
Abstract

In the current scenario, Alzheimer's disease is a complex, challenging, and arduous health issue, and its prevalence, together with comorbidities, is accelerating around the universe. Alzheimer's disease is becoming a primary concern that significantly impacts an individual's status in life. The traditional treatment of Alzheimer's disease includes some synthetic drugs, which have numerous dangerous side effects, a high risk of recurrence, lower bioavailability, and limited treatment. Hence, the current article is a detailed study and review of all known information on plant-derived compounds as natural anti-Alzheimer's agents, including their biological sources, active phytochemical ingredients, and a possible mode of action. With the help of a scientific data search engine, including the National Center for Biotechnology Information (NCBI/PubMed), Science Direct, and Google Scholar, analysis from 2001 to 2024 has been completed. This article also described clinical studies on phytoconstituents used to treat Alzheimer's disease. Plant-derived compounds offer promising alternatives to synthetic drugs in treating Alzheimer's disease, with the potential for improving cognitive function and slowing down the progression of the disease. Further research and clinical trials are needed to fully explore their therapeutic potential and develop effective strategies for managing this complex condition.

Authors: Shweta Gandhi, Priya Shah, Rajat Goyal, Rupesh Gautam, Hitesh Chopra

DOI: 10.5937/scriptamed55-49700

Volume55
Issue5
Pages603-622
Abstract

Urinary tract infections (UTIs) are common health issues that occur frequently in both women and men. These infections occur in the urinary tract, leading to discomfort and potential complications. Prompt medical attention is essential to diagnose and treat UTIs effectively. Aim of this research was to provide an overview of effective complementary strategies in the management of UTIs. This review paper focuses on the current and future treatment strategies for UTI infections. Various natural remedies have been investigated as potential complementary therapies to enhance health outcomes for UTI patients. The efficacy of frequently employed natural products, including cranberry juice/extracts, ascorbic acid, hyaluronic acid, probiotics and multi-component formulations designed for the treatment and prevention of UTIs, has been explored. The probiotics serve to break down food and increase our immunity. Usually, multiple doses of antibiotics are used to treat these infections, but there are many side effects and bacterial resistance rates are increasing. Complementary UTI management strategies, including effective dietary regimens and new formulations, are attaining approvals. Drinking liquids daily significantly suppresses UTI infections. Incorporating daily consumption of cranberry juice may still be regarded as a viable complementary strategy to aid in the management of UTI infections.

Authors: Sohini Mukherjee, Hitesh Chopra, Rajat Goyal, Sihao Jin, Zhenzhen Dong, Tanmoy Das, Tanima Bhattacharya

DOI: 10.1186/s11671-024-04100-x

Volume19
Issue1
Pages1-28
Abstract

The exploration of targeted therapy has proven to be a highly promising avenue in the realm of drug development research. The human body generates a substantial amount of free radicals during metabolic processes, and if not promptly eliminated, these free radicals can lead to oxidative stress, disrupting homeostasis and potentially contributing to chronic diseases and cancers. Before the development of contemporary medicine with synthetic pharmaceuticals and antioxidants, there was a long-standing practice of employing raw, natural ingredients to cure a variety of illnesses. This practice persisted even after the active antioxidant molecules were known. The ability of natural antioxidants to neutralise excess free radicals in the human body and so prevent and cure a wide range of illnesses. The term "natural antioxidant" refers to compounds derived from plants or other living organisms that have the ability to control the production of free radicals, scavenge them, stop free radical-mediated chain reactions, and prevent lipid peroxidation. These compounds have a strong potential to inhibit oxidative stress. Phytochemicals (antioxidants) derived from plants, such as polyphenols, carotenoids, vitamins, and others, are central to the discussion of natural antioxidants. Not only may these chemicals increase endogenous antioxidant defenses, affect communication cascades, and control gene expression, but they have also shown strong free radical scavenging properties. This study comprehensively summarizes the primary classes of natural antioxidants found in different plant and animal source that contribute to the prevention and treatment of diseases. Additionally, it outlines the research progress and outlines future development prospects. These discoveries not only establish a theoretical groundwork for pharmacological development but also present inventive ideas for addressing challenges in medical treatment.

Authors: Philips Kumar, Prantik Kishor Chakroborty, Kashish Wilson, Rajat Goyal, Sumeet Gupta, Anjali Saharan, Nidhi Rani, Prerna Sharma

DOI: 10.2174/0115733947299954240730062858

Volume21
Issue6
Pages757-770
Abstract

Cosmetics are items that are used to glorify or change facial looks and appearance as well as provide fragrance to the body. Their main aim is to cleanse, beautify, facilitate attractiveness, and change physical looks. Women use many different beauty products, such as skin care, hair, perfume, oral hygiene, and nail care items, which may include harmful substances that are threatening to their health. The controversy around cosmetics and beauty products promoting cancer threat has grown over the previous few years. According to data from the European Cancer Registries, postmenopausal and very young women are now seeing an increase in the occurrence of breast cancer, which is the more frequent form of cancer in women. Genetic predisposition, long-term hormone replacement treatment, and various environmental variables, including air pollution, agrochemicals, alcohol, and specific consumer goods like cosmetic additives, are some of the causes of breast cancer. Additionally, the USFDA made all adverse event reports, including those involving concerns about cosmetics, publicly accessible via the Adverse Event Reporting System (CAERS) of the Centre for Food Safety and Applied Nutrition in 2016. In this period of modernization, CAERS is of limited use since there is a lack of different supporting data, such as demographic information, medical history, or linked product usage, and because the existing data is vulnerable to severe reporting bias. Despite the system's potential to protect the public's health, the database's future usefulness will depend on a wide range of reporting participants, more thorough reporting, and concurrent investments in regulatory science and enhanced molecular techniques.

Authors: Rakesh Pahwa, Swati Saini, Jatin Chhabra, Rajat Goyal, Shobhit Kumar, Rajendra Awasthi, Harish Dureja

DOI: 10.1186/s43088-024-00528-3

Volume13
Issue69
Pages1-19
Abstract

AbstractErlotinib is a reversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor that acts by inhibiting signaling pathways, resulting in the disruption of cancerous cell proliferation. Erlotinib is a promising anticancer agent mainly utilized in the mitigation of non-small cell lung cancer cells (NSCLC) and pancreatic tumor. Apart from NSCLC and pancreatic tumor, erlotinib has also been employed in different malignancies, including metastatic colorectal cancer, malignant glioma, breast cancer, gastrointestinal cancers, etc. Despite erlotinib’s distinctive qualities as a targeted drug, its applications are still limited by poor solubility, variable oral bioavailability, a high daily dose requirement, large protein binding, and primitive or acquired therapeutic resistance. Nanotechnology is a favorable approach to increase therapeutic effectiveness of erlotinib. It is one of the newest scientific field directed toward the diagnosis and targeted treatment of cancer. This technology aids in the distinction between normal and malignant cells, which overlays the strategy for targeted delivery. This manuscript discussed the advances of erlotinib nanoformulations in the management of different cancers. Moreover, the manuscript also comprises various research outcomes of erlotinib nanoformulations with other therapeutic agents as combinational therapy. Erlotinib can be delivered to a precise target in the body utilizing different polymers, lipids, and metals.

Authors: Anjna Sharma, Ameya Sharma, Divya Dheer, Raghu Rai Sharma, Vivek Puri, Shabana Bibi, Amina Shamas, Sameeullah Memon, Rajat Goyal, Priyanka, Hitesh Chopra

DOI: 10.1097/js9.0000000000002001

Volume110
Issue11
Pages6873-6882
Abstract

Hepatic encephalopathy and other neurodegenerative disorders have profound implications for extensive liver impairment, calling for new ways of treating the condition. The application of stem cell transplantation to treat these severe disorders is a new and encouraging technique. This review article digs deep into the subject of stem cell transplantation therapy, neurodegenerative disorders associated with advanced liver damage, and liver transplantation. It comprehensively analyses the background, rationale, scope, and objectives of using stem cells to treat such challenging conditions. The topic of discussion includes the subtleties of neurodegenerative disorders, the function of liver transplantation, and the possible advantages and disadvantages associated with it. The relevance of patient selection, intraoperative concerns and post-transplant care is discussed. Further, the article explores how stem cell-based therapies can benefit from nanotechnology, specifically how it can improve stem cell distribution, survival, and integration for better therapeutic results. This review aims to offer a thorough analysis of regenerative medicine’s present and future possibilities in dealing with the intricate relationship between neurodegeneration and liver damage. It does this by examining the efficacy, safety, and long-term impacts of stem cell transplantation in treating neurodegenerative disorders associated with advanced liver damage. This will incorporate insights from ongoing clinical trials, the patent landscape, and future directions. The goal is to pave the way for innovative and personalized treatment approaches in this evolving research and clinical practice field. Therefore, these efforts represent a promising frontier in medical research that can alleviate the burden of HE and associated neurological complications combined with liver cirrhosis.

Authors: Jiao Wang, Rajat Goyal, Rupesh K. Gautam, Kajal Garg, Shaheen Husain, Hitesh Chopra, Ankit Kumar Dubey, Rehab A. Rayan, Mohammad Amjad Kamal, Dinesh Kumar Mishra, Rohit Gundamaraju, Bairong Shen, Rajeev K. Singla

DOI: 10.2174/0113892010293479240709074020

Volume26
Issue10
Pages1532-1548
Abstract

As the world recovers from the COVID-19 pandemic, a resurgence in MPXV cases is causing serious concern. The early clinical similarity of MPXV to common ailments like the flu and cold, coupled with the resemblances of its progressing rash to other infections, underscores the importance of prompt and accurate diagnosis. Among the infections, smallpox is clinically closest to MPXV, and rashes similar to MPXV stages also appear in syphilis and varicella zoster. A comprehensive review of MPXV, herpes, and syphilis was carried out, including structural and morphological features, origins, transmission modes, and computational studies. PubMed literature search on MPXV, using MeSH key terms, yielded 1904 results, with the analysis revealing prominent links to sexually transmitted diseases. More in-depth exploration of MPXV, Herpes Simplex Virus (HSV), and Syphilis revealed further disease interconnections and geographical correlations. These findings emphasize the need for a holistic understanding of these interconnected infectious agents for better control and management.

Authors: Hitesh Chopra, Kavita Munjal, Rajat Goyal, Kashish Wilson, Kuldeep Dhama

DOI: 10.5937/scriptamed55-49150

Volume55
Issue3
Pages343-355
Abstract

Onychomycosis, commonly referred to as nail fungus, is a persistent and difficult-to-treat condition that affects both toes and fingernails. Even though traditional treatments such as antifungal medications and topical ointments are effective in some cases, they are often associated with significant side effects and a high recurrence rate. There has been a growing interest in alternative and complementary treatments in recent years, including natural remedies and new pharmaceutical formulations, which are becoming increasingly popular. This review aims to explore the current state of knowledge surrounding onychomycosis treatment and its challenges, with a particular focus on the benefits and limitations of the current therapeutic options. Also, light is shed on the prospects available as treatment options.

Authors: Mohini Devi, Prabhjeet Kaur Bamrah, Rajat Goyal, Manjusha Choudhary, Hitesh Chopra

DOI: 10.34133/jbioxresearch.0006

Volume7
Issue0
Pages1-16
Abstract

Background: Inflammatory diseases are among the leading causes of health issues that considerably influence health care costs. Despite the notable advancements in medical treatment that have been made in recent years, natural products with biological activity still play essential roles in a variety of anti-inflammatory conditions. The study and identification of novel treatments for the adverse effects of available synthetic anti-inflammatory agents warrant further attention. Objective: This study focused on the emerging therapeutic potential of terpenoid products as anti-inflammatory agents. Methods: The literature reveals that secondary metabolites obtained from medicinal plants, viz. terpenes and terpenoids and their nanoformulations, are effective for the treatment of inflammation in humans. Established terpenes are a broad class of secondary metabolites that are rich in monoterpenes, diterpenes, triterpenes, tetraterpenes, ceramides, and sesquiterpenes and have various therapeutic applications, such as antitumor, antibacterial, antimicrobial, analgesic and anti-inflammatory activities. Numerous studies have shown that terpenes can decrease inflammation-associated symptoms by reducing the release of proinflammatory cytokines, including nuclear transcription factor-kappa B, interleukins, tumor necrosis factor-alpha, and other inflammatory mediators. Conclusion: This review describes the latest knowledge of the different terpenoid-derived natural and synthetic compounds that have been isolated from plant sources in recent years and their anti-inflammatory potential and therapeutic mechanism of action. Furthermore, this study focused on terpenoid-based nanoformulations with enhanced bioavailability and improved therapeutic efficacy as anti-inflammatory agents.

Authors: Aashish Kumar, Rajat Goyal, Kajal Garg, Sumeet Gupta, Kashish Wilson, Hitesh Chopra

DOI: 10.34133/jbioxresearch.0002

Volume7
Issue0
Pages1-12
Abstract

Background: Renal calculi, commonly known as kidney stones, is a prevalent urological condition that affects a substantial portion of the population worldwide. The formation of kidney stones is a complex process influenced by various factors, including diet, fluid intake, genetics, and metabolic abnormalities. The pathogenesis of renal calculi involves a complex interplay of multiple factors, including supersaturation of urine with stone-forming constituents, urinary supersaturation, crystallization, and aggregation. Objective: This review aims to provide an overview of the present understanding of renal calculi, their pathophysiology, diagnostic approaches, and available treatment modalities. Methods: This review discusses the different types of kidney stones, such as calcium oxalate, calcium phosphate, uric acid, and struvite stones, and explores their formation mechanisms and associated risk factors. The management of renal calculi relies on stone characteristics, patient symptoms, stone size, and location. Furthermore, counseling and education regarding lifestyle modifications and risk factor management are essential for long-term management. Conclusion: Accurate diagnosis and appropriate management based on stone characteristics and patient symptoms are essential for successful outcomes. Preventive strategies to reduce stone recurrence are vital for long-term management and patient well-being. However, further research is needed to refine diagnostic techniques, improve treatment options, and enhance the understanding of the underlying pathophysiology of renal calculi.

Authors: Rajat Goyal, Pooja Mittal, Rupesh K. Gautam, Mohammad Amjad Kamal, Asma Perveen, Vandana Garg, Athanasios Alexiou, Muhammad Saboor, Shafiul Haque, Aisha Farhana, Marios Papadakis, Ghulam Md Ashraf

DOI: 10.1186/s12986-024-00800-4

Volume21
Issue1
Pages1-15
Abstract

AbstractNeurodegenerative diseases represent one of the utmost imperative well-being health issues and apprehensions due to their escalating incidence of mortality. Natural derivatives are more efficacious in various preclinical models of neurodegenerative illnesses. These natural compounds include phytoconstituents in herbs, vegetables, fruits, nuts, and marine and freshwater flora, with remarkable efficacy in mitigating neurodegeneration and enhancing cognitive abilities in preclinical models. According to the latest research, the therapeutic activity of natural substances can be increased by adding phytoconstituents in nanocarriers such as nanoparticles, nanogels, and nanostructured lipid carriers. They can enhance the stability and specificity of the bioactive compounds to a more considerable extent. Nanotechnology can also provide targeting, enhancing their specificity to the respective site of action. In light of these findings, this article discusses the biological and therapeutic potential of natural products and their bioactive derivatives to exert neuroprotective effects and some clinical studies assessing their translational potential to treat neurodegenerative disorders. Graphical Abstract Common mechanisms, therapeutic targets, and molecular pathogenesis of neurodegeneration. It is focused on the biological and therapeutic potential of natural products and their bioactive derivatives to exert a neuroprotective effect on the pathologies of neurodegenerative diseases.

Authors: KARAN WADHWA, PAYAL CHAUHAN, SHOBHIT KUMAR, RAKESH PAHWA, RAVINDER VERMA, RAJAT GOYAL, GOVIND SINGH, ARCHANA SHARMA, NEHA RAO, DEEPAK KAUSHIK

DOI: 10.32604/or.2024.047278

Volume32
Issue5
Pages877-897
Abstract

The present research work aimed at the formulation of film-coated microspheres incorporating glibenclamide drug and their evaluation for the management of diabetes mellitus (DM). Microspheres were prepared by solvent evaporation methodology by the usage of ethyl cellulose as polymer, ethanol and dichloromethane as solvents and Tween 80® as a non-ionic surfactant. The film-coated membrane was prepared by pan coating method, incorporating ethyl cellulose, isopropyl alcohol, diethyl phthalate and sodium lauryl sulfate. This film membrane was coated on microspheres with the help of a spray gun. The efficiency of entrapment of the film coated microspheres of F5* batch, among different formulations, is highest and comes out to be in the range of 76.65±0.58. The percentage yield was observed to be 73.32±0.14. Morphological studies conducted by scanning electron microscope show spherical microspheres of uniform size. In vitro drug release study conducted of the coated microspheres of glibenclamide shows the highest amount of release of 97.44% in the F5*batch. The best-fit model was determined by the highest R2 value. Further, the developed formulation helps in reduction in dose dumping, with better patient compliance, and also masks the bitter taste of the drug.

Authors: , Nitu Patidar, Nadeem A. Farooqui, Darshan Jamindar, , Dinesh K. Mishra, , Rajat Goyal, , Hitesh Chopra, , Rupesh K. Gautam

DOI: 10.53879/id.61.02.14270

Volume61
Issue2
Pages51-56
Abstract

The present research work aimed at the formulation of film-coated microspheres incorporating glibenclamide drug and their evaluation for the management of diabetes mellitus (DM). Microspheres were prepared by solvent evaporation methodology by the usage of ethyl cellulose as polymer, ethanol and dichloromethane as solvents and Tween 80® as a non-ionic surfactant. The film-coated membrane was prepared by pan coating method, incorporating ethyl cellulose, isopropyl alcohol, diethyl phthalate and sodium lauryl sulfate. This film membrane was coated on microspheres with the help of a spray gun. The efficiency of entrapment of the film coated microspheres of F5* batch, among different formulations, is highest and comes out to be in the range of 76.65±0.58. The percentage yield was observed to be 73.32±0.14. Morphological studies conducted by scanning electron microscope show spherical microspheres of uniform size. In vitro drug release study conducted of the coated microspheres of glibenclamide shows the highest amount of release of 97.44% in the F5*batch. The best-fit model was determined by the highest R2 value. Further, the developed formulation helps in reduction in dose dumping, with better patient compliance, and also masks the bitter taste of the drug.

Authors: Rajat Goyal, Kashish Wilson, Anjali Saharan, Rupesh K. Gautam, Hitesh Chopra, Sumeet Gupta, Mohammad Amjad Kamal

DOI: 10.37349/emed.2024.00208

Volume5
Issue0
Pages89-100
Abstract

Nerve cell death is the central aspect of human neurodegenerative disorders. Neuronal death in results leads to the onset of various human neurological disorders such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis, and stroke. In developing neurons, apoptosis is assumed to provide a counterbalance to overexuberant cell replication. Numerous signals may induce apoptosis in neurons, such as the absence of neurotrophic factor support, increased levels of metabolic and oxidative stress, and overstimulation of glutamate receptors (leading to the calcium influx). Cell death and neurological disorders have been related to oxidative stress, which creates an imbalance between antioxidant defenses and free radical production. In this paper, a summary of the engrossment of oxidative stress, neuronal apoptosis, and mitochondrial dysfunction in neurodegenerative disorders has been discussed. Antioxidant therapy’s potential assistance for neurodegenerative illnesses in human beings is still up for dispute, despite encouraging pre-clinical research findings. One elucidation for this disparity could be the non-existence of an accurate way to assess oxidative stress in the brain. The explosion in research on apoptosis in neurodegeneration has stemmed from the conception that persuading neuronal apoptotic death may be crucial to the progression of a disease and that anti-apoptotic approaches may be useful in the prevention of neurodegenerative processes. A deeper understanding of the role that apoptosis plays in neurodegenerative processes will serve as the foundation for future research into the development of focused, effective treatment modalities.

Authors: Rajat Goyal, Sumeet Gupta, Prabodh Sharma, Manu Sharma

DOI: 10.2174/0127722708278736231205055035

Volume18
Issue1
Pages2-10
Abstract

Abstract: Non-steroidal anti-inflammatory drugs (NSAIDs) have a long history in the healthcare system due to their therapeutic potential. These NSAIDs cause ulcerogenicity, stomach pains, gastrointestinal hemorrhage, mucosa bleeding, and pancreatitis when used moderately and consistently. With researchers, managing the aforementioned adverse effects therapeutically is getting increasingly difficult. One method for creating NSAID moieties with low penetration as well as ulcerogenic properties is the prodrug technique. During the oral consumption of NSAID-prodrugs, ulcerations, intestinal hemorrhage, and mucosa hemorrhage have significantly decreased. Considering this background, this review focussed on NSAID prodrugs as well as their justifications, the pathogenesis of NSAIDs inducing gastrointestinal toxicity, and the role of different antioxidants and spacer groups. Prodrug moieties have more advantages over parent medicines concerning both solubility and lipophilicity. In general, NSAID-class prodrugs can successfully treat both acute and long-term inflammation and aches without causing ulcerotoxicity and related gastrointestinal side effects, which reduces their burden from the pharmacoeconomic perspective.

No matching articles

Try another word from the title, author or DOI.

Brief Bio

Mr. Rajat Goyal is an Assistant Professor of Pharmaceutical Chemistry at MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana-Ambala, Haryana, India. He completed his Bachelor of Pharmacy (2014-2018) and Master of Pharmacy in Pharmaceutical Chemistry (2018-2020) from the Institute of Pharmaceutical Sciences, Kurukshetra University, Kurukshetra, Haryana, India. In 2021, he qualified the Graduate Pharmacy Aptitude Test (GPAT) and is currently pursuing his Ph.D. at MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana-Ambala, Haryana, India. Mr. Goyal has a strong research profile with an H-index 16 and has authored more than 70 review and research articles, along with 25 book chapters published in reputed international journals. He has also authored one book, currently under proof-reading. His intellectual property portfolio includes three patent applications and one copyright, with one patent and the copyright already published. He actively participated in national and international conferences, faculty development programs, seminars and workshops, and has delivered numerous oral and poster presentations. In recognition of his research excellence, he received the Best Paper Award at the DBT-Sponsored International Conference on “Research Ethics, Clinical Therapeutics and Phytopharmaceutical Drug Research”, organized by MM College of Pharmacy in collaboration with MMIMSR & MMCON, MM(DU), Mullana-Ambala in February 2024. In addition to his academic and research contributions, he serves as a reviewer for several reputed international journals published by Elsevier, Springer, Wiley, Hindawi, and other leading publishers

Affiliations

Nothing added yet.

Education

Nothing added yet.

Honors & Awards

Nothing added yet.

Society Memberships

Nothing added yet.

Expertise

Nothing added yet.

Specialty

Nothing added yet.

Suggested researchers

Madhur Gupta
NKP Salve Institute of Medical Sciences & Research Centre and Lata Mangeshkar Hospital, Nagpur, Maharashtra, India
105 publications
DK
Dupinder Kaur
19 publications
VK
Vishnu Kumar Gupta
University of Rajasthan, Jaipur
20 publications
Mohamed Mesregah MD
Menoufia University Faculty of Medicine
79 publications
Fathi M Sherif
University of Tripoli, Pharmacy, Pharmacology
31 publications
Ghouse Modin Mamdapur
Information and Documentation
30 publications
Dr. Dukre Tushar Pradip
College of Pharmaceutical Sciences, PIMS (DU), Loni.
34 publications
AG
Asiye Gölpek Karababa
Hasan Kalyoncu Üniversitesi
17 publications
Girendra Kumar Gautam
Shri Ram College of Pharmacy, Muzaffarnagar
63 publications
MS
Mahesh Shivananjappa
16 publications
Mgr. Hovsep Kocharyan, Ph.D.
Palacky University Olomouc (Czech Republic)
18 publications

Following

Nobody here yet.

Followers

Nobody here yet.

29 Publications